icon-folder.gif   Conference Reports for NATAP  
 
  EASL 44th Annual Meeting
April 22-26, 2009
Copenhagen, Denmark		 Back grey_arrow_rt.gif
 
 
 
Tenofovir 2 Years Safety, Efficacy & Resistance in Patients with Cirrhosis
 
 
  Reported by Jules Levin
EASL April 2009 Copenhagen

Conclusions-1.gif

WIth-2.gif

Summary-3.gif

Term-4.gif

Subseets-5.gif

TDF-6.gif

ITT-7.gif

Serolgy-8.gif

not-9.gif